TMCI Insider Trading Activity and SEC Form 4 Filings
TMCI insider trading summary
Over the past 12 months, insiders at Treace Medical Concepts, Inc. (TMCI) reported 13 open-market purchases worth $1.3M by 1 insider and no sales on SEC Form 4. Net insider buying was $1.3M.
Latest TMCI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 24, 2026 | John T. Treace | Chief Executive Officer | Buy | $48K (11,000 @ $4.34) |
| Aug 21, 2026 | John T. Treace | Chief Executive Officer | Buy | $22K (5,000 @ $4.35) |
| Aug 20, 2026 | John T. Treace | Chief Executive Officer | Buy | $177K (39,944 @ $4.44) |
| Jun 11, 2026 | John T. Treace | Chief Executive Officer | Buy | $40K (9,891 @ $4.04) |
| Jun 11, 2026 | John T. Treace | Chief Executive Officer | Buy | $93K (22,887 @ $4.04) |
| Jun 10, 2026 | John T. Treace | Chief Executive Officer | Buy | $118K (29,430 @ $4.02) |
| Jun 10, 2026 | John T. Treace | Chief Executive Officer | Buy | $59K (14,715 @ $4.02) |
| May 28, 2026 | John T. Treace | Chief Executive Officer | Buy | $185K (61,202 @ $3.02) |
| May 27, 2026 | John T. Treace | Chief Executive Officer | Buy | $143K (49,810 @ $2.87) |
| May 26, 2026 | John T. Treace | Chief Executive Officer | Buy | $13K (4,508 @ $2.79) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.